Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase NA 2 Phase 1 1

Status

Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3499 Neoplasms 2740 Prostatic Neoplasms 1583 Colorectal Neoplasms 1248 Lung Neoplasms 1188 Motor Activity 766 Head and Neck Neoplasms 621 Pancreatic Neoplasms 601 Colonic Neoplasms 586 Uterine Cervical Neoplasms 567 Carcinoma, Non-Small-Cell Lung 560 Carcinoma, Hepatocellular 559 Rectal Neoplasms 516 Stomach Neoplasms 493 Brain Neoplasms 438 Anxiety Disorders 401 Ovarian Neoplasms 399 Pain 376 Esophageal Neoplasms 347 Polycystic Ovary Syndrome 341 Neoplasm Metastasis 340 Fatigue 324 Urinary Bladder Neoplasms 314 Precursor Cell Lymphoblastic Leukemia-Lymphoma 303 Melanoma 298 Depression 286 Multiple Myeloma 283 Endometrial Neoplasms 263 Lymphoma 258 Hematologic Neoplasms 251

Interventions

Sorafenib 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

2 trials

Recent Start date Enrollment

Phase NA × OTHER × HCC × Clear all

NCT06766773 2025-01-10

CWSRIH-HCC

The First People's Hospital of Neijiang

Phase NA Active not recruiting

HCC

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡